Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma

NCT01282346 is registered in ClinicalTrials.gov with SOLX, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01282346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma
Lead sponsor
SOLX, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2015
Enrollment
116 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, glaucoma, open angle